NEW YORK (GenomeWeb News) — Solexa today said it has tapped New England Biolabs to provide it with “certain key enzymes and other reagents” for its genome-analysis system, and to manufacture its sequencing-by-synthesis polymerase.
Financial terms of the agreement were not disclosed.